Citius Pharmaceuticals CTXR
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.78 | 80 | -11.15 | -8 | -6.06 | 140 |
| 2025Q3 | 1.24 | 68 | -12.00 | -8 | -6.16 | 131 |
| 2025Q2 | 1.59 | 65 | -13.98 | -9 | -7.06 | 128 |
| 2025Q1 | 1.49 | 61 | -17.32 | -11 | -9.02 | 121 |
| 2024Q4 | 4.00 | 65 | -14.42 | -10 | -8.23 | 121 |
| 2024Q3 | 12.52 | 70 | -13.85 | -11 | -10.10 | 117 |
| 2024Q2 | 14.59 | 86 | -12.81 | -11 | -11.26 | 97 |
| 2024Q1 | 22.43 | 79 | -10.41 | -9 | -9.08 | 91 |
| 2023Q4 | 18.91 | 85 | -10.52 | -9 | -9.18 | 97 |
| 2023Q3 | 17.11 | 91 | -10.55 | -10 | -9.29 | 104 |
| 2023Q2 | 30.00 | 98 | -8.98 | -8 | -7.90 | 110 |
| 2023Q1 | 29.25 | 91 | -10.99 | -11 | -9.75 | 104 |
| 2022Q4 | 19.75 | 100 | -3.54 | -4 | -3.18 | 112 |
| 2022Q3 | 30.25 | 103 | -7.52 | -8 | -6.82 | 114 |
| 2022Q2 | 23.00 | 110 | -7.80 | -9 | -7.15 | 120 |
| 2022Q1 | 44.75 | 118 | -6.26 | -8 | -5.70 | 128 |
| 2021Q4 | 38.50 | 124 | -7.20 | -9 | -6.59 | 138 |
| 2021Q3 | 50.75 | 132 | -3.69 | -5 | -3.43 | 142 |
| 2021Q2 | 87.00 | 137 | -4.45 | -6 | -4.14 | 147 |
| 2021Q1 | 44.50 | 125 | -5.48 | -4 | -4.85 | 135 |